Laurence Bocket
Overview
Explore the profile of Laurence Bocket including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diarra A, Meybeck A, Derdour V, Degrendel M, Tetart M, Aissi E, et al.
AIDS Patient Care STDS
. 2025 Feb;
39(3):81-83.
PMID: 39950950
No abstract available.
2.
Alidjinou E, Coulon P, Tetart M, Guigon A, Diarra A, Aissi E, et al.
J Antimicrob Chemother
. 2025 Jan;
PMID: 39849847
Introduction: The specificity of HIV-1 DNA genotypic resistance tests (GRTs) is hampered by the detection of the APOBEC-context drug resistance mutations (AC DRMs), usually harboured by replication-incompetent proviruses. We sought...
3.
Soulie C, Balde A, Fofana D, Charpentier C, Bonnafous P, Sourice J, et al.
J Antimicrob Chemother
. 2024 Jun;
79(8):1974-1984.
PMID: 38884154
Background: Doravirine is the latest NNRTI to be approved for the treatment of HIV-1 and has a different resistance profile from first-generation NNRTIs. Our aim was to investigate the virological...
4.
Becquart A, Guigon A, Regueme A, Coulon P, Bocket L, Hober D, et al.
Diagn Microbiol Infect Dis
. 2024 Feb;
109(1):116226.
PMID: 38394738
Diagnosis of hepatitis E virus (HEV) infection relies first on detection of IgM antibodies (Ab), sometimes completed with HEV RNA detection. This study aimed to compare the performance of two...
5.
Andre-Garnier E, Bocket L, Bourlet T, Hocqueloux L, Lepiller Q, Maillard A, et al.
J Antimicrob Chemother
. 2024 Jan;
79(3):578-588.
PMID: 38269616
Objectives: As many disparities in the clinical use of HIV DNA sequencing are observed, a DELPHI-type consensus was initiated in France to homogenize use, techniques and interpretation of results. Methods:...
6.
Ouafi M, Regueme A, Alcaraz I, Riviere P, Bazus H, Salmon-Rousseau A, et al.
J Med Virol
. 2022 Nov;
95(1):e28276.
PMID: 36326021
The ongoing outbreak of monkeypox virus (MPXV) is the largest one in historically non-endemic countries. Early reports described atypical epidemiological and clinical presentations. We investigated MPXV DNA detection in oropharyngeal...
7.
Alidjinou E, Demaret J, Corroyer-Simovic B, Vuotto F, Miczek S, Labreuche J, et al.
Clin Microbiol Infect
. 2022 Oct;
29(2):258.e1-258.e4.
PMID: 36257549
Objectives: We investigated serum neutralizing activity against BA.1 and BA.2 Omicron sublineages and T cell response before and 3 months after administration of the booster vaccine in healthcare workers (HCWs)....
8.
Hirabidian M, Bocket L, Demaret J, Vuotto F, Rabat A, Faure K, et al.
J Clin Virol
. 2022 Aug;
155:105268.
PMID: 35998394
Background: Neutralizing antibodies (NAbs) against SARS-CoV-2 have been shown to correlate with protection against infection. Simple tools such as lateral flow assays (LFA) that can accurately measure NAbs may be...
9.
Gerber Z, Daviaud C, Delafoy D, Sandron F, Alidjinou E, Mercier J, et al.
Sci Rep
. 2022 Jul;
12(1):12561.
PMID: 35869099
The COVID-19 pandemic caused by the new Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to threaten public health and burden healthcare systems worldwide. Whole SARS-CoV-2 genome sequencing has become...
10.
Ouafi M, Dubos F, Engelmann I, Lazrek M, Guigon A, Bocket L, et al.
J Clin Virol
. 2022 Jul;
153:105221.
PMID: 35777223
Objectives: Viral respiratory infections are common in children, and usually associated with non-specific symptoms. Respiratory panel-based testing was implemented during the COVID-19 pandemic, for the rapid differentiation between SARS-CoV-2 and...